United States · FDA National Drug Code directory
Cyclobenzaprine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43547-399_0318717e-68e2-48bc-aa86-d34101d2bd25
- Product NDC
- 43547-399
- Form
- TABLET, FILM COATED
- Composition / generic term
- cyclobenzaprine hydrochloride
- Labeler
- Solco Healthcare U.S., LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170330
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43547-399-01) · 43547-399-01
- 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43547-399-10) · 43547-399-10
- 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43547-399-11) · 43547-399-11
- 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43547-399-50) · 43547-399-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →